Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins alongside ...

Near the dawn of the 20th century, human life expectancy began to jump significantly thanks to new scientific insights into matters like handwashing, vaccines, and food safety. In recent decades, ...

NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat ...

NewLimit, a 1.5-year-old, San Francisco-based, 17-person company that aims to increase the number of healthy years each person lives by epigenetically reprogramming cells, is today announcing that it ...

NewLimit, a startup that aspires to reverse aging by manipulating cells, announced on Tuesday that it's raised $40 million in a Series A round from Kleiner Perkins and other venture firms, and from ...

$105 million is the initial investment for Antiaging company NewLimit and additional funding available upon reasonable progress. the Coinbase founder, Brian Armstrong, has a net worth of over $10 ...

NewLimit was one of eight Bay Area startups that raised some $336 million in combined funding at midweek. After a slow start to the week, the Bay Area's venture and startup scene saw a veritable ...